Entry into mitosis during the somatic cell cycle is regulated in response to signals that monitor the completion of DNA replication, the integrity of the nuclear genome, and, possibly, the increase in cellular mass during the cell cycle. It has been postulated that the operation of this cell cycle control involves the gradual accumulation of rate-limiting mitotic inducers, which trigger nuclear division when their cellular concentration reaches a critical level. We have cloned a human gene, which we call CDC25, whose product may function as a mitotic inducer. This human gene encodes a protein with a predicted molecular mass of 53,000 daltons whose C-terminal domain shares about 37% sequence identity with the fission yeast cdc25+ mitotic inducer. The human CDC25 gene rescues the defect of a fission yeast temperaturesensitive (ts) cdc25ts mutant that is unable to initiate mitosis. In HeLa cells CDC25 mRNA levels are very low in GI and increase at least 4-fold as cells progress towards M phase. These data suggest that in human cells, as in fission yeast, the accumulation of CDC25 mitotic inducer during G2 may play a key role in regulating the timing of mitosis.
(1-5). The products of these genes operate in a control network that determines cell size at mitosis and thereby coordinates growth with division. These mitotic control elements appear to act together to regulate function of the p34cdc2 M-phase protein kinase, whose activity is believed to be rate-limiting for the initiation of M phase (4) (5) (6) (7) . The mitotic inducer encoded by cdc25+ plays a key role in this control. In wild-type cells, cdc25+ gene function is required for entry into mitosis, p34cdc2 dephosphorylation, and kinase activation (2, 3, (6) (7) (8) (9) . Incremental increases in cdc25+ gene dosage cause a corresponding decrease in cell size at mitosis, showing that the level of cdc25+ expression is rate-limiting for entry into M phase in wild-type cells (3) . It has been shown recently that in fission yeast the levels of cdc25+ mRNA and protein increase as cells proceed through interphase, peaking at mitosis (10) . These data suggest that in fission yeast the cell cycle timing of mitosis is regulated by the cyclic accumulation of the cdc25 mitotic inducer, which when accumulated to a critical level, brings about p34cdc2 kinase activation and the initiation of mitosis (11) (12) (13) .
One of the best strategies to investigate the mitotic control in mammalian cells is to identify mammalian homologs of fission yeast mitotic control elements. One approach to this has been to rescue yeast mitotic control mutations with mammalian cDNA libraries made in expression vectors. Although this method was used to clone a human cdc2 homolog (14) , the success of this approach has so far been limited. We have used a two-stage strategy that circumvents potential problems to clone a human cdc25 homolog. In the first stage, a cdc25 homolog from the highly divergent budding yeast Saccharomyces cerevisiae was cloned by rescue of a fission yeast temperature-sensitive (ts) cdc25ts mutation (15) . The isolation of a S. cerevisiae cdc25 homolog, named MIHI, established that the cdc25 mitotic inducer gene was conserved among broadly divergent species and identified sequence similarities that were also likely to be generally conserved among eukaryotes. Here we report the second stage of this approach in which we have used the sequence similarities between the two yeast cdc25 homologs and a Drosophila cdc25 homolog that has been independently identified by genetic analysis (16) to design a pair of highly degenerate oligonucleotide sets that were then used to clone a human cdc25 homolog by polymerase chain reaction (PCR) (17, 18) . The product of the human cdc25 homolog shares a conserved C-terminal domaint with the yeast and Drosophila cdc25 proteins. The human cdc25 homolog rescues a fission yeast cdc25Ss mutant, indicating functional as well as structural conservation of cdc25 homologs. We also report that the human cdc25 homolog, which we call CDC25, is expressed predominantly in G2 phase in HeLa cells, indicating that periodic accumulation of the cdc25 mitotic inducer may be an evolutionarily conserved feature of the mitotic control in somatic cells.
MATERIALS AND METHODS
Cloning Human CDC25 cDNA. The 40-mer 5' degenerate oligonucleotide set had the sequence: 5'-ATCTAGATC GAINATNGAYTGYMGNTWYGARTAYGART-3', where R = A + G, Y = T + C, M = A + C, S = G = C, and W = A + T. The underlined sequence contains Xho I and Cla I restriction enzyme sites, and the 3' proximal 28 nucleotides correspond to the peptide sequence Ile-Ile-Asp-CysArg-(Phe or Tyr)-Glu-Tyr-Glu-(Phe or Tyr). This oligonucleotide is 16 tThe sequence reported in this paper has been deposited in the GenBank data base (accession no. M34065).
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,ug of each oligonucleotide set, and 5 jig of a HeLa cDNA library made in vector pCD (19) by Steve Hanks (Salk Institute) and kindly provided by Steve Gould (University of California, San Diego). Forty cycles of 94°C for 1 min, 45°C for 2 min, and 72°C for 3 min were performed in a DNA thermal cycler (Perkin-Elmer/Cetus). The reaction products were digested with Cla I and Xho I restriction enzymes and separated on a 1.5% agarose gel; the 280-nucleotide product was cloned into the Cla I/Xho I-digested vector pBluescript SK (pBSK) (Stratagene). Three clones were sequenced. They all were at least 99% identical. The HeLa CDC25 PCR clone was used as a probe to obtain cDNA clones from a HeLa (D98/AH-2) cDNA library in vector Lambda ZAP II (Stratagene). pBSK phagemids were derived by in vivo excision using the manufacturer's protocol. The longest clone, pBSK1, was sequenced completely.
Expression of Human CDC25 cDNA in Fission Yeast. The complete CDC25 cDNA from pBSK1 was isolated by digestion with BamHI and Xho I (the BamHI site is at the 3' end Proc. Natl. Acad. Sci. USA 87 (1990) of the gene) and then ligated into pSM1 and pSM2 digested with BamHI and Xho I. The pSM plasmids are pBR322/ LEU2/2-,um chimeras containing the simian virus 40 early promoter upstream of a polylinker (20, 21) . The pSM2 clone containing CDC25 cDNA in correct transcription orientation was called pSM25H, and the pSM1 derivative containing CDC25 cDNA in the opposite orientation was called pSM25H-rev. Both plasmids were transformed into a Sc. pombe cdc25-22 leul-32 ura4-D18 strain. Transformants were isolated, grown to midlogarithmic phase in EMM +leucine liquid medium (22) at 25°C, collected by centrifugation, and resuspended in YES medium (22) . These cultures were incubated at 25°C for 4 hr and then incubated for a further 6 hr at 35°C. Cell number was monitored with a Coulter Counter model ZM. Cells were stained with Calcofluor (fluorescent brightener 28, Sigma F-6259).
Analysis of Human CDC25 mRNA Levels. Cell synchrony and RNA blot hybridization (Northern) analysis were performed as described (23 T 130  610  620  630  640  650  660  670  680  690  700  710  720 CCGAATGGTTTGGACCG I 170   730  740  750  760  770  780  790  800  810  820  830  840 ACTACTGTTLCC-AAAATGGATAAAAATCCAAACCTAGGuAGmA~tAGACCAGGCuAGAAGAGATTTCAGATGAATTAATGGAGTTTTCCCTGAAAGATCAAGAAbCAGG~~mTG.u~AwmCAGAGTGC G 210  850  860  870  880  890  900  910  920  930  940  950  960 CTATATCGCTCCCCGTCGATGCCAGAGAAC-TTG~AatACAGGCC.AAGACTGAAGCAGGTGGAAAAAA TCAAG;GACAACACAATACCAGATAAAGTTAAAAAAGTAmTT-CTG7GCL-u~CAAGGA G 250  970  980  990  1000  1010  1020  1030  1040  1050  1060  1070  1080 AAGCTCAGGAGGGCTT GCGCTGCCAACCGTGTCAGGGAAACACCAALaTCGAAGTATGTCAACCCAGAAACAGTGGCTGCCTTACTGTCGGGGAAGTTCCAGGGTCTGATTGAGAAGT Y 410   1450  1460  1470  1480  1490  1500  1510  1520  1530  1540  1550   1560 ATCCTTi AAAGGCIGIGITACAGAGACTTCTTTCCAGAATATATGGAACTGTGTGAACAC GT IaTG CTATGCATCATCAGGACCAC At AIT (Fig. 1) . This protein shares a conserved C-terminal region with the other known cdc25 homologs (Fig. 2) The human CDC25 gene was placed under the control of the simian virus 40 early promoter, which directs moderate levels of expression in fission yeast (20) . Plasmid pSM25H contained CDC25 cDNA in the correct orientation for expression. A plasmid containing CDC25 cDNA in the reverse orientation, pSM25H-rev, was used as a control. These plasmids were transformed into a cdc25-22 leul-32 ts mutant. Cell number was monitored as logarithmic-phase transformant cultures were shifted from 250C to 350C. Plasmid pSM25H rescued the cdc25-22 G2 arrest, whereas pSM25H-rev did not (Fig. 3A) . The cdc25-22 leul-32 mutant transformed with pSM25H was able to grow and to divide at 350C until reaching stationary phase. The degree of rescue was variable among individual cells (probably a result of variation in plasmid copy number), but most of the cells divided at 1-2 times wild-type size (Fig. 3B ). Plasmid pSM25H also was able to rescue a mutant in which the CDC25 gene had been deleted (data not shown). These data establish that the human homolog of cdc25 is able to function as a mitotic inducer in fission yeast and suggests that CDC25 is likely to function in the mitotic control in human cells.
Human CDC25 Gene Is Expressed Predominantly in G2. To further explore the possibility that human CDC25 functions as a mitotic inducer gene in human cells, we next determined if CDC25 mRNA is expressed periodically in the HeLa cell cycle. HeLa cells grown in suspension culture were separated on the basis of size by centrifugal elutriation (see Materials and Methods). Cell cycle profiles of the fractions were monitored by flow-cytometry analysis of propidium iodide-stained cells to measure nuclear DNA content. The samples were processed for total RNA, and Northern blots of the samples were probed with CDC25 and 8i-actin gene probes. The first fractions eluted, containing the smallest cells, were highly enriched in cells that were in G. phase (Fig.  4A) . The human CDC25 mRNA levels were very low in these cells and increased as the fraction of G2+M cells in the samples increased. The level of a f-actin mRNA remained constant through the cell cycle. Laser densitometry of the autoradiograph indicated that the level of CDC25 mRNA relative to ,3-actin mRNA increased about 4-fold from the first to the last fraction.
We wished to verify these findings using an independent method of cell synchronization. A population of HeLa cells arrested in S phase was prepared by using a double thymidine block (23) . Upon removal of thymidine, the majority of the cells proceeded through S phase and entered G2 in a syn- chronous fashion (Fig. 4B) . Northern blot analysis showed that human CDC25 mRNA levels rose as cells progressed from S into G2 phase, followed by a decrease as cells proceeded further into G1. These data establish that the level of human CDC25 mRNA increases as HeLa cells progress into G2 phase and approach mitosis. At the present time we don't know if the periodic increase in CDC25 mRNA level is due to increased transcription or increased stability of the mRNA. Genetics: Sadhu et al.
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0", species (P.R., unpublished data). We have used the same approach to clone homologs of fission yeast sucl+ and budding yeast CKSJ genes, which encode small proteins that interact with the p34cdc2/CDC28 mitotic kinase (25) . Roles of the Putative CDC25 Mitotic Inducer. We have presented evidence showing that the human CDC25 gene shares a number of structural and functional features with cdc25 homologs identified in the yeasts and Drosophila. Human CDC25 encodes a protein of predicted molecular mass of 53 kDa, which is very close to the predicted molecular mass of 54 kDa for the Drosophila and budding yeast cdc25 homologs. The fission yeast cdc25 protein has a somewhat larger predicted molecular mass of 67 kDa. The C-terminal half of the human CDC25 protein ranges in identity from about 25% to 45% relative to the C-terminal regions of the other cdc25 homologs. No primary sequence homology is apparent between any of the N-terminal halves ofthe cdc25 homologs. This suggests that sequences essential and possibly sufficient for function are located in the Cterminal halves of the cdc25 homologs. This suggestion is supported by the observation that expression of a truncated form of the MIHJ gene product, lacking the N-terminal quarter of the protein, complemented the product of a fission yeast cdc25Ss mutation (15) .
Expression of human CDC25 in fission yeast rescued a cdc2ts mutation, showing that the product of the human cdc25 homolog is capable of functioning as a mitotic inducer in fission yeast. Although we do not yet have any direct evidence establishing a mitotic function of CDC25 in human cells, the rescue of a fission yeast cdc25Ss mutation by CDC25, together with data demonstrating mitotic inducer functions for cdc25 homologs in the budding yeast and Drosophila (15, 16) , strongly suggest that CDC25 is likely to function as an inducer in the mitotic control of human cells.
The proposed mitotic function of human CDC25 is further supported by the observation that CDC25 mRNA is predominantly expressed late in the cell cycle. A similar pattern of cdc25 gene expression has been seen in the mitotic cell cycles of fission yeast and Drosophila (10, 16) . In fission yeast it has been shown that appearance of the cdc25+ gene product, a phosphoprotein migrating with the apparent molecular mass of 80 kDa, oscillates during the cell cycle, increasing during G2 and peaking at mitosis. In fission yeast it has been shown that the level of cdc25+ expression is rate-limiting for the initiation of mitosis, and it has been proposed that the cyclic accumulation of p8Ocdc25 during interphase drives the mitotic cycle in fission yeast (3, 10) . The apparent similarities of gene function and pattern of expression of the cdc25 homologs suggest the possibility that the mitotic cycle of some types of human cells may be driven by the rate of accumulation of CDC25 gene product during G2.
Although genetic evidence from fission yeast indicates that cdc25 protein, p80cdc25, functions as a mitotic inducer by promoting activation of the p34cdc2 protein kinase (3, 4), the biochemical mechanism by which this occurs remains unknown. However, new biochemical evidence suggests that p80cdc25 may be involved in regulating the p34cdc2 kinase activity by modifying the phosphorylation state of p34cdc2* Upon shift of a cdc25's mutant from the permissive to restrictive temperature, cells arrest in late G2 with inactive p34cdc2 kinase (6, 7) . At the arrest point, p34cdc2 is maximally phosphorylated on tyrosine and threonine residues (9) . Upon shift of cdc25'S cells down to the permissive temperature, p34cdc2 rapidly becomes dephosphorylated and activated as a kinase. These observations, together with mutagenesis studies showing that alteration of the p34cdc2 tyrosine phosphorylation site enhances its activity as a mitotic inducer, suggest that p34cdc2 is activated by dephosphorylation (9) . We propose that cdc25 mitotic inducer promotes the dephosphorylation of p34cdc2, either by activating phosphatases or inhibiting kinases.
